FOLH1 and thyroid cancer: The study showed no significant differences in [68Ga]Ga-PSMA-11 PET/CT uptake between patients with de-differentiated thyroid cancer and those with well-differentiated thyroid cancer, although PSMA immunohistochemical staining results showed significant differences in PSMA expression between well-differentiated and de-differentiated thyroid cancer.